DIANA SUTHERLAND: Open Payments
NPI 1346633765 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,093 in 36 payments from 11 companies in 2025. Trend: 2023 $7,715 · 2024 $11,296 · 2025 $10,093
Speaker / faculty: $6,790Travel & lodging: $1,845Food & beverage: $1,358Education: $100
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 18 | $9,370 |
| Novartis Pharmaceuticals Corporation | 7 | $227 |
| Daiichi Sankyo Inc. | 2 | $221 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| ABBVIE INC. | 1 | $26 |
| TerSera Therapeutics LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: Trodelvy, Enhertu, SCEMBLIX, KISQALI, ELAHERE, Zoladex, KEYTRUDA, OJJAARA.
Industry payments across OH — which companies pay providers there.
